Page last updated: 2024-10-31

methylphenidate and CACH Syndrome

methylphenidate has been researched along with CACH Syndrome in 1 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reddick, WE1
Taghipour, DJ1
Glass, JO1
Ashford, J1
Xiong, X1
Wu, S1
Bonner, M1
Khan, RB1
Conklin, HM1

Other Studies

1 other study available for methylphenidate and CACH Syndrome

ArticleYear
Prognostic factors that increase the risk for reduced white matter volumes and deficits in attention and learning for survivors of childhood cancers.
    Pediatric blood & cancer, 2014, Volume: 61, Issue:6

    Topics: Age Factors; Antineoplastic Agents; Attention; Attention Deficit Disorder with Hyperactivity; Brain;

2014